News | Radiology Imaging | February 02, 2022

Federal panel identifies critical need to improve equity and access as cancer screening rates lag

Urgent and immediate action must be taken to ensure more effective and equitable implementation of cancer screening, according to a report released today by the President's Cancer Panel.

February 2, 2022 — Urgent and immediate action must be taken to ensure more effective and equitable implementation of cancer screening, according to a report released today by the President's Cancer Panel. The Panel's reportClosing Gaps in Cancer Screening: Connecting People, Communities, and Systems to Improve Equity and Accessfinds that too many Americans — particularly those in communities of color and socially/economically-disadvantaged populations — are presenting with more advanced disease at the time of diagnosis, enduring aggressive treatment, or dying from cancers that could have been detected at earlier, more treatable stages. Additionally, the Panel found that many people do not receive timely, appropriate follow-up care after an abnormal result. The Panel concludes that more effective and equitable implementation of cancer screening can and will save lives and reduce the burden of cancer.

The Panel noted that at one point during the COVID-19 era, the U.S. experienced a 90-percent reduction of cancer screenings. "While screening rates were not high enough prior to 2020, during the pandemic, cancer screenings such as mammograms, colonoscopies, HPV and PAP tests, and lung cancer screenings were postponed or canceled, in many cases labeled as 'elective.' We must correct the misperception that cancer screening is 'elective,'" said John P. Williams, M.D., chair of the President's Cancer Panel. "We need to learn from the time of disruption and seize this time of opportunity because the long-term impact of missed or delayed screenings is that more people will die from cancer."

The report acknowledges there is no single barrier responsible for gaps in cancer screening uptake; some barriers are specific for a certain cancer type, while many reach across all types of cancer screening. These include lack of awareness or understanding, lack of provider recommendation, logistical challenges, fear and stigma, and concerns about cost. 

The Panel sought input from stakeholders in multiple sectors who participated in a series of working groups that informed the development of the report and the Panel's recommendations. The Panel's report outlines a multipronged approach to connect and support people, communities, and systems for cancer screening and follow-up after an abnormal result.

The Panel identified four critical goals and related recommendations to ensure the benefits of cancer screening reach all populations:

  • Improve and align communication through communications campaigns and expanded National Cancer Roundtables;
  • Facilitate equitable access by providing and increasing funding for community-oriented outreach and support, including robust engagement of community health workers and increasing patient access to self-sampling;
  • Strengthen workforce collaborations by empowering all members of the healthcare team to support cancer screening and expand access to genetic testing; and
  • Create effective health IT to make systems work better for providers and patients by creating computable guidelines and clinical decision support tools.

For more information:

Related content on lung cancer screening:

Racial/Ethnic Disparities Persist in Lung Cancer Screening Eligibility

Primary Lung Cancers Detected by LDCT are at Lower Risk of Brain Metastases

Physician and Patient Groups Call On CMS to Update Medicare Lung Cancer Screening Coverage

USPSTF Expands Lung Cancer Screening Eligibility Thresholds 

Low-dose CT for Lung Cancer Screening: Benefit Outweighs Potential Harm

Related Content

Webinar | Information Technology

Postpandemic staffing shortages and increased volumes require radiologists to do more with less, exacerbating burnout ...

Time January 30, 2023
News | Stereotactic Breast Imaging

January 27, 2023 — According to an accepted manuscript published in ARRS’ American Journal of Roentgenology (AJR), both ...

Time January 27, 2023
News | Digital Pathology

January 27, 2023 — Fujifilm has completed its asset purchase of Inspirata, Inc.’s digital pathology business effective ...

Time January 27, 2023
News | Artificial Intelligence

January 26, 2023 — MedCognetics, Inc., an Artificial Intelligence (AI) software firm, announced that it has been awarded ...

Time January 26, 2023
News | Magnetic Resonance Imaging (MRI)

January 25, 2023 — On November 11th, 2022 at the Southern Hills Hospital in Las Vegas, USA, Robotic Spine Surgeon Dr ...

Time January 25, 2023
Feature | Enterprise Imaging

The Imaging Technology News (ITN) team was saddened to hear of the untimely passing of Frank Pecaitis, US North American ...

Time January 24, 2023
Feature | Radiology Imaging | By Melinda Taschetta-Millane

Have you read the January/February 2023 issue of Imaging Technology News? If not, take some time out of your busy ...

Time January 24, 2023
News | Breast Imaging

January 24, 2023 — For patients with cancer, lengthy delays in treatment can decrease their chances of survival. In an ...

Time January 24, 2023
News | Digital Radiography (DR)

January 24, 2023 — Carestream Health was awarded 20 new patents in 2022 for global advances in artificial intelligence ...

Time January 24, 2023
News | Radiology Imaging

January 23, 2023 — Canon Medical Systems has released a new eBook featuring its new medical imaging roadshow. This new ...

Time January 23, 2023
Subscribe Now